Millrace Asset Group Inc. Invests $1.22 Million in Omnicell, Inc. (NASDAQ:OMCL)

Millrace Asset Group Inc. bought a new position in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 28,043 shares of the company's stock, valued at approximately $1,223,000. Millrace Asset Group Inc. owned approximately 0.06% of Omnicell as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Arizona State Retirement System lifted its holdings in shares of Omnicell by 2.9% during the 2nd quarter. Arizona State Retirement System now owns 12,853 shares of the company's stock worth $348,000 after acquiring an additional 357 shares during the period. Diversified Trust Co lifted its holdings in shares of Omnicell by 3.3% in the second quarter. Diversified Trust Co now owns 15,364 shares of the company's stock worth $416,000 after acquiring an additional 494 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Omnicell by 78.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock valued at $55,000 after purchasing an additional 553 shares during the last quarter. Louisiana State Employees Retirement System increased its position in Omnicell by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 23,100 shares of the company's stock worth $625,000 after purchasing an additional 600 shares in the last quarter. Finally, Curi RMB Capital LLC increased its holdings in shares of Omnicell by 0.7% during the third quarter. Curi RMB Capital LLC now owns 88,815 shares of the company's stock worth $3,872,000 after buying an additional 651 shares in the last quarter. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OMCL has been the subject of several research reports. StockNews.com downgraded Omnicell from a "buy" rating to a "hold" rating in a research report on Friday, November 15th. JPMorgan Chase & Co. raised their price objective on shares of Omnicell from $37.00 to $44.00 and gave the company a "neutral" rating in a report on Thursday, November 21st. Benchmark reissued a "buy" rating and set a $48.00 target price on shares of Omnicell in a report on Wednesday, October 9th. Bank of America reaffirmed a "neutral" rating and set a $57.00 target price (up from $44.00) on shares of Omnicell in a report on Thursday, October 31st. Finally, Craig Hallum raised their price objective on Omnicell from $45.00 to $64.00 and gave the stock a "buy" rating in a research report on Thursday, October 31st. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, Omnicell currently has an average rating of "Hold" and a consensus target price of $52.00.

Omnicell Stock Performance

Shares of OMCL stock traded down $0.51 during mid-day trading on Tuesday, hitting $45.45. The company's stock had a trading volume of 418,232 shares, compared to its average volume of 539,236. The company's fifty day simple moving average is $44.29 and its 200-day simple moving average is $37.57. Omnicell, Inc. has a 52 week low of $25.12 and a 52 week high of $55.74. The company has a market cap of $2.11 billion, a PE ratio of -117.85, a P/E/G ratio of 38.42 and a beta of 0.81.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.